Sanofi-Aventis Recherche & Developpement

Immune-Mediated Inflammatory Diseases

Clinical research includes ulcerative colitis, Crohn’s disease, rheumatoid arthritis, systemic lupus erythematosus, and systemic juvenile idiopathic arthritis, with additional interest in coeliac disease and chronic graft versus host disease.

  • Ulcerative colitis
  • Crohn’s disease
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Chronic graft versus host disease

Research also extends to immune thrombocytopenia, autoimmune haemolytic anaemia, and other immune system diseases.

Dermatology and Allergic Disease

Studies cover atopic dermatitis, psoriasis, hidradenitis suppurativa, pruritus, and chronic rhinosinusitis with nasal polyps, alongside asthma and other respiratory tract diseases.

  • Atopic dermatitis
  • Psoriasis
  • Hidradenitis suppurativa
  • Asthma
  • Chronic rhinosinusitis with nasal polyps

Additional activity includes chronic obstructive pulmonary disease and bronchiectasis within broader respiratory disease research.

Haematology, Oncology, and Plasma Cell Disorders

Research spans multiple myeloma, plasma cell myeloma, relapsed/refractory multiple myeloma, acute myeloid leukemia, acute lymphocytic leukaemia, and myelodysplastic syndrome.

  • Multiple myeloma
  • Acute myeloid leukemia
  • Acute lymphocytic leukaemia
  • Myelodysplastic syndrome
  • Non-small cell lung cancer

Other areas include solid tumours, plasma cell myeloma recurrent, and light-chain amyloidosis.

Neurology and Neuromuscular Disorders

Clinical studies address multiple sclerosis, relapsing multiple sclerosis, progressive multiple sclerosis, amyotrophic lateral sclerosis, and chronic inflammatory demyelinating polyneuropathy.

  • Multiple sclerosis
  • Amyotrophic lateral sclerosis
  • Chronic inflammatory demyelinating polyneuropathy
  • Polyneuropathy
  • Neurological disorders

Research also includes inflammatory demyelinating polyradiculoneuropathy and broader nervous system diseases.

Metabolic, Genetic, and Rare Diseases

Work in this area includes type 1 diabetes mellitus, Fabry disease, Gaucher’s disease type III, glycogen storage disease type II, and achondroplasia.

  • Type 1 diabetes mellitus
  • Fabry disease
  • Gaucher’s disease type III
  • Achondroplasia
  • Congenital, hereditary and neonatal diseases

Additional interest is shown in hemophilia, transplant rejection, Usher’s syndrome, and other nutritional and metabolic diseases.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effects of Itepekimab for Patients with Chronic Rhinosinusitis Without Nasal Polyps

    Not recruiting

    Investigated drugs:
    Belgium France Italy Poland Portugal Romania +1
  • Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Greece +7
  • Study on the Effects of Itepekimab in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Greece Hungary Italy Poland +2
  • Study on Frexalimab for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia France Germany Spain
  • Study on the Long-Term Safety of SAR422459 for Patients with Stargardt’s Disease

    Not recruiting

    1 1
    Investigated diseases:
    France
  • Study on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Estonia France Germany Hungary +6